Renown Belgian hospital to acquire Elekta Unity MR-Linac and Versa radiation therapy systems
BRUSSELS, January 20, 2020 - Elekta (EKTA-B.ST) announced today that it signed a contract with the Institut Jules Bordet,
Elekta's Head of Region Europe,
The comprehensive cancer center is gearing up for its new cancer clinic with an investment in state-of-the-art technology and upgrades to existing devices. This includes Elekta Unity, a transformative magnetic resonance radiation therapy (MR/RT) system, which combines a high-field MRI scanner with a best-in-class linear accelerator to enable personalized precision radiation therapy.
The institute already enjoys Elekta solutions, including Leksell Gamma Knife[®] Icon™ and two Elekta Infinity linacs as well as MOSAIQ and
Software upgrades are scheduled for delivery during 2020 and the linear accelerators, including Unity, in 2021.
# # #
For further information, please contact:
Tel: +46 70 410 7180, e-mail: Oskar.Bosson@elekta.com
Time zone: CET: Central European Time
Tel: +46 76 611 76 25, e-mail: cecilia.ketels@elekta.com
Time zone: CET: Central European Time
This is information that
About Elekta Unity
Elekta Unity is a state-of-the art MR-linac that is defining a new standard for personalized radiation therapy based on real-time high resolution anatomical and biological MRI at the point-of-care. Unity combines a Philips high-field 1.5T MRI scanner with a best-in-class 7MV linear accelerator and breakthrough online dose replanning software that are fully integrated to enable adaptive radiotherapy and real-time target monitoring.
About Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our nearly 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to - and benefits from - more precise, personalized radiotherapy treatments. Headquartered in
https://news.cision.com/elekta/r/institut-jules-bordet-invests-in-elekta-s-latest-cancer-treatment-technology,c3012235
https://mb.cision.com/Main/35/3012235/1177017.pdf
(c) 2020 Cision. All rights reserved., source